HIM
TTHI

Hillsdale Investment Management’s TRANSITION THERAPEUTICS INC (CANADA) TTHI Stock Holding History

Hillsdale Investment Management’s Portfolio TTHI Stock Details TTHI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-85,100
Closed -$274K – 616
2013
Q2 		$274K Buy
+85,100
New +$241K 0.09% 213

Other funds holding TTHI

OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
VC
Vestor Capital Chicago, Illinois $1.59M AUM 51.04% 1-Year Est. Return
CI
Cowen Inc New York $1.39B AUM 60.14% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
FNBT
FineMark National Bank & Trust Fort Myers, Florida $3.2B AUM 18.28% 1-Year Est. Return
SKK
Shepherd Kaplan Krochuk Boston, Massachusetts $119M AUM 8.32% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

Hillsdale Investment Management's TTHI Position: Q3 2013 in Review

Hillsdale Investment Management sold out of TRANSITION THERAPEUTICS INC (CANADA) (TTHI) in Q3 2013, closing a stake of 85,100 shares — an estimated $274K sold.

Hillsdale Investment Management first reported a position in TTHI in Q2 2013 and held it in 1 quarter. The position peaked at $274K in Q2 2013. 24 funds tracked by Wall St. Rank hold TTHI as of Q3 2013.

  • Hillsdale Investment Management reported no remaining TRANSITION THERAPEUTICS INC (CANADA) position as of Q3 2013 after selling out during the quarter.
  • Hillsdale Investment Management sold 85,100 TRANSITION THERAPEUTICS INC (CANADA) shares in Q3 2013, an estimated $274K.
  • Hillsdale Investment Management first reported a position in TRANSITION THERAPEUTICS INC (CANADA) in Q2 2013 and held it in 1 quarter.
  • Hillsdale Investment Management's TRANSITION THERAPEUTICS INC (CANADA) position peaked at $274K in Q2 2013.
  • 24 funds tracked by Wall St. Rank held TRANSITION THERAPEUTICS INC (CANADA) as of Q3 2013.

Based on Hillsdale Investment Management's 13F filing for Q3 2013, filed 14 Nov 2013.